A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

South Korea's Hyundai ADM Bio plans to launch global clinical trials of its new drug, Penetrium, for rheumatoid arthritis and ...

BioNTech has initiated a Phase III clinical trial for its oncology candidate BNT324 in metastatic castration-resistant prostate cancer, aiming to compare the drug against current standard chemotherapy ...

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are denied access to abiraterone, and the charity said it will "continue to ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

CHICAGO -- There is more evidence that taking vitamin E pills can be risky. A study that followed up on men who took high doses of the vitamin for about five years found they had a slightly increased ...